Current disease status-Recurrent cancer-Metastatic recurrence - Page 6 of 11 Posts on Medivizor
Navigation Menu

Current disease status-Recurrent cancer-Metastatic recurrence Posts on Medivizor

Retargeting: Treatment for metastatic HER2+ breast cancer that has progressed following targeted treatment

Retargeting: Treatment for metastatic HER2+ breast cancer that has progressed following targeted treatment

Posted by on Jul 18, 2015 in Breast cancer | 0 comments

In a nutshell The authors reviewed the benefits and safety of ado–trastuzumab emtansine (Kadcyla), a treatment for metastatic breast cancer (cancer that has spread to other areas of the body). Some background Human epidermal growth factor receptor 2 positive (HER2) breast cancer depends on HER2 for growth. Treatments that target the HER2...

Read More

Hormone and targeted therapy in the treatment of bone tumors in metastatic prostate cancer

Hormone and targeted therapy in the treatment of bone tumors in metastatic prostate cancer

Posted by on Jul 9, 2015 in Prostate cancer | 0 comments

In a nutshell The authors analyzed the effect of using hormone therapy and targeted therapy, in combination, to treat bone tumors in prostate cancer patients. Some background Hormone therapy is a common treatment for prostate cancer. It reduces the level of male sex hormones (e.g. testosterone) in the body or prevent them from affecting...

Read More

Can brain metastasis in melanoma be predicted early?

Can brain metastasis in melanoma be predicted early?

Posted by on Jun 27, 2015 in Melanoma | 0 comments

In a nutshell The authors evaluated the factors that could predict development of brain metastasis in melanoma patients. Some background In advanced melanoma, cancer often spreads to the brain (brain metastasis). The functional changes in the body that accompany the symptoms of brain metastasis are currently unknown. However, if patients are...

Read More

Is there a link between KRAS mutations and the risk of colorectal cancer spreading to the lungs?

Is there a link between KRAS mutations and the risk of colorectal cancer spreading to the lungs?

Posted by on Jun 15, 2015 in Colorectal cancer | 0 comments

In a nutshell This study investigated whether mutations (permanent change) in the KRAS gene can predict the development of lung metastases (spread of cancer to the lungs from the rectum or colon) in advanced colorectal cancer. Some background Colorectal tumors can have genetic mutations. One of the most common mutations is of the KRAS gene-an...

Read More

Is capecitabine better with lapatinib or trastuzumab for HER2 positive metastatic breast cancer?

Is capecitabine better with lapatinib or trastuzumab for HER2 positive metastatic breast cancer?

Posted by on Apr 28, 2015 in Breast cancer | 0 comments

In a nutshell This paper studied the effect of lapatinib (Tyverb) plus capecitabine (Xeloda) versus trastuzumab (Herceptin) plus capecitabine in patients with human epidermal growth factor receptor 2 (HER2) positive breast cancer that has spread to other parts of the body. Some background Trastuzumab is used  to treat HER2 positive breast...

Read More

Calling on patients with colorectal cancer that has spread to the liver to test a drug treatment option

Calling on patients with colorectal cancer that has spread to the liver to test a drug treatment option

Posted by on Apr 24, 2015 in Colorectal cancer | 0 comments

In a nutshell This study is being carried out in New York and New Jersey. It will examine whether adding panitumumab (Vectibix) to chemotherapy reduces the risk of the cancer returning in colorectal cancer patients with liver metastases (cancer that has spread to the liver). The authors will also record any adverse events experienced and patient...

Read More